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MYOCARDIAL INFARCTION AND VULNERABLE PLAQUE





Virmani et al.(2007) 
Common criterion for plaque vulnerability is fibrous cap <65µm. 
Necrotic core size and cap stiffness also play a role.
REGIONS OF HIGH CIRCUMFERENTIAL STRESS
CORRELATE WITH RUPTURE SITES
Models predict rupture in the shoulders or regions of high curvature. 
Rupture threshold
Does not explain how
Maehara et al.(2002)
However, 40% of the ruptures are 
found in the center of the cap.
3
Finet et al. (2004)
Cheng et al. (1993)
Tang et al. (2005)
caps >50 µm rupture.
EXPLOSIVE GROWTH OF SMALL VOIDS AT THE POLES OF A SPHERICAL
INCLUSION IN AN ELASTOMERIC MATERIAL UNDER TENSION
Theory first proposed by Goodier (1933) to explain rupture 
due to solid impurities in rubber tires 
(Gent and Park, 1984)Large particle: interfacial debonding
Small particle: cavitation near surface
Very small particle: surface energy too large
THE µ-CALC HYPOTHESIS
 Vengrenyuk et al. PNAS (2006) propose that rupture caused by 
either cavitation or interfacial debonding due to small cellular level 
microcalcifications in the fibrous cap proper. 
 Such calcifications had not previously been seen in IVUS, OCT or 
MRI. 
 Goodier (1933) infinite medium theory extended to thin fibrous caps.
5
Histological section of ruptured cap
from Virmani showing µCalc at rupture
site. 
Burke et al. (1997) estimate cap
thickness as 23±19 µm. 
Virmani et al (2003) 95% of all ruptures
Occur in caps < 65 µm.
Ruptured  cap stained with H&E
µ-CALCS ARE VISIBLE WITH µ-CT
6Vengrenyuk et al. (2006)
STRESS CONCENTRATION PREDICTED 
AT TENSILE POLES OF THE µ-CALCS
7
Spherical µCalc doubles PCS 
near interface at poles
Vengrenyuk et al. (2006)
Key insight:
Cavitation   σ=(E+P)/2
,  E=500 to1000 kPa
300< σ < 550kPa
FEA stress calculations indicate stress 
concentration  at the poles of the µ-
calcs.




Series of µCT images at 6.7µm 
resolution showing a bubble 
growing at the interface of 
µCalcs in fibrous cap.
THOUSANDS OF CORONARY µ-CALCS




3%      d>200µm
CVF
Samples came from patients with
atherosclerosis, ages 51-80. 
9
µ-CALCS IN THE CAP ARE RARE
• Less than 0.2% of the
calcifications are in the cap proper
where they could be dangerous.
• 9 of 62 vulnerable lesions had
µCalcs in cap, 81 µCalcs total.
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Rare case where 35µm µCalc 
localized at site of cap rupture 
and thrombus detached. 
 Finite Element Analysis 
Submodeling allows us to 
greatly refine the stress 
calculations at the 
interface of the µ-calcs.












FINITE ELEMENT MODEL MESH OPTIMIZATION
This
elongated
calcification Linear  tetrahedron mesh
Results  in stress concentration differ 






PCS by a 
factor of  3.5
Edge size 3µm
Edge size 5µm Edge size 8µm
Quadratic  tetrahedron mesh
Refined  linear mesh
4n
100n








1 5 4.2 138 3 2
2 5 2.5 103 5 0
3 16 3.5 144 6 10
4 11 2.6 41 4 7
5 15 3.4 48 12 3
6 9 5 106 3 6
7 11 4.29 133 7 4
8 5 2.17 275 5 0
9 4 2 92 2 2
Total 81 47 34
Mean 9.00 3.30 120.00 5.22 3.78
SD 4.56 1.05 68.73 2.99 3.35
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58% 42%
53 lesions no µcalcs in cap, thinnest cap 66 µm, PCS 107kPa << 300kPa
Basic paradox: Why are there no non-ruptured lesions between 30-66 µm
STRESS CONCENTRATION PREDICTED 
AT µ-CALCS
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Tissue stress concentrations five times the background 
stress can result from the close clustering of µCalcs.
EFFECT ON PCS OF A µCALC EMBEDDED IN
FIBROUS CAPS OF DIFFERENT TISSUE STIFFNESS
15
Changes in the Eintima increase PCS 30%, while the presence of a 
µCalc increases PCS >80%. 25µm µCalc in 120µm thick cap.
CONCLUSIONS
 µ-Calcs, invisible in current clinical techniques, 
were found to be abundant, but just a few of them, 
less than 0.2%, were present in the fibrous cap 
proper.
 At 6.7um resolution 9 out of 62 caps (15%) 
exhibited µ-Calcs. 81 µ-Calcs in total.
 µ-Calcs are present at the rupture site.
 A µ-Calc increases the PCS by a factor of 2 to 5 
depending on shape factor and clustering.
 The presence of µ-Calcs in the cap is more 
important than variation in tissue properties.
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